NCT01358877 2025-11-28
APHINITY
Hoffmann-La Roche
Phase 3 Completed
Clinical Trials
53 trialsNCT03013504 2024-11-06
TROIKA
Prestige Biopharma Limited
Phase 3 Completed
NCT00630032 2024-02-21
TavIx
UNICANCER
Phase 3 Completed
NCT00129922 2023-03-06
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
Spanish Breast Cancer Research Group
Phase 3 Completed
NCT01726452 2022-09-30
NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
Cancer Trials Ireland
Phase 3 Completed
NCT00087178 2022-08-11
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
NSABP Foundation Inc
Phase 3 Completed
NCT03556358 2022-01-14
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With HerceptinĀ® in HER2+ Early Breast Cancer
Tanvex BioPharma USA, Inc.
Phase 3 Completed
NCT02395640 2021-10-26
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer
Fudan University
Phase 3 Completed
NCT00003606 2021-02-21
Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
UNICANCER
Phase 3 Completed
NCT02324088 2021-02-21
PEGASE07
UNICANCER
Phase 3 Completed
NCT01690702 2021-02-02
GAIN-2
GBG Forschungs GmbH
Phase 3 Completed
NCT00309569 2020-10-14
Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients
Austrian Breast & Colorectal Cancer Study Group
Phase 3 Completed
NCT01026116 2020-05-12
A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old
Fudan University
Phase 3 Completed
NCT00052910 2020-05-07
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT04127019 2020-02-26
Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)
Fudan University
Phase 3 Completed
NCT02115204 2019-10-03
4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF
West German Study Group
Phase 3 Completed
NCT01049425 2019-08-14
planB
West German Study Group
Phase 3 Completed
NCT02042690 2019-05-29
Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
Peking University
Phase 3 Completed
NCT00776724 2019-05-06
TaiNAC
National Taiwan University Hospital
Phase 3 Completed
NCT00689156 2018-04-05
READ
Danish Breast Cancer Cooperative Group
Phase 3 Completed
NCT00950300 2018-01-23
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT02001506 2017-08-29
Neo-shorter
Asan Medical Center
Phase 3 Completed
NCT02125344 2017-07-13
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
GBG Forschungs GmbH
Phase 3 Completed
NCT00544232 2016-02-15
Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
GBG Forschungs GmbH
Phase 3 Completed
NCT00540800 2016-01-14
BREAST-10
National Cancer Institute, Naples
Phase 3 Completed
NCT01433614 2015-09-17
TEX
Karolinska University Hospital
Phase 3 Completed
NCT02450058 2015-05-21
MIG5
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Phase 3 Completed
NCT00424606 2015-05-20
Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients
Hellenic Oncology Research Group
Phase 3 Completed
NCT00718354 2015-05-13
GASTRANOX
Thrombosis Research Institute
Phase 3 Completed
NCT00002870 2014-12-16
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
UNICANCER
Phase 3 Completed
NCT00196872 2014-07-17
A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)
GBG Forschungs GmbH
Phase 3 Completed
NCT01985724 2014-05-14
Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
Hellenic Oncology Research Group
Phase 3 Completed
NCT01053390 2013-12-20
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 3 Completed
NCT00002615 2013-12-19
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003577 2013-12-19
Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003893 2013-12-19
Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00017095 2013-10-24
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00288002 2013-08-26
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00963729 2013-08-12
Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00054587 2013-07-19
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
UNICANCER
Phase 3 Completed
NCT00311636 2013-06-26
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00055679 2013-06-18
Combination Chemotherapy in Treating Women With Stage I Breast Cancer
UNICANCER
Phase 3 Completed
NCT00123318 2013-06-18
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
Trans Tasman Radiation Oncology Group
Phase 3 Completed
NCT00047099 2013-05-30
Combination Chemotherapy in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002529 2013-04-04
12-93
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT00002784 2013-04-04
15-95
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT00004934 2013-02-04
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00038402 2012-07-20
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00336791 2012-02-14
Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00309556 2011-12-30
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
Austrian Breast & Colorectal Cancer Study Group
Phase 3 Completed